Search Results

There are 4623 results for: content related to: Gonadotropin-releasing hormone: An update review of the antagonists versus agonists

  1. You have free access to this content
    Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  2. You have free access to this content
    Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study

    BJU International

    Volume 106, Issue 2, July 2010, Pages: 182–187, Fritz H. Schröder, Bertrand Tombal, Kurt Miller, Laurent Boccon-Gibod, Neal D. Shore, E. David Crawford, Judd Moul, Tine Kold Olesen and Bo-Eric Persson

    Version of Record online : 13 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08981.x

  3. GnRH blockers: a changing paradigm in the management of prostate cancer

    International Journal of Urological Nursing

    Volume 3, Issue 3, November 2009, Pages: 85–92, Lawrence Drudge-Coates

    Version of Record online : 8 JAN 2010, DOI: 10.1111/j.1749-771X.2009.01081.x

  4. You have free access to this content
    Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer

    BJU International

    Volume 104, Issue 11, December 2009, Pages: 1580–1584, Roger S. Kirby, John M. Fitzpatrick and Noel Clarke

    Version of Record online : 10 NOV 2009, DOI: 10.1111/j.1464-410X.2009.08924.x

  5. You have free access to this content
    New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist

    BJU International

    Volume 110, Issue 4, August 2012, Pages: 499–504, Marc B. Garnick and Nicolas Mottet

    Version of Record online : 16 NOV 2011, DOI: 10.1111/j.1464-410X.2011.10708.x

  6. You have free access to this content
    Degarelix: a new hormonal treatment for prostate cancer

    Future Prescriber

    Volume 10, Issue 1, January 2009, Pages: 11–15, Professor Malcolm Mason

    Version of Record online : 26 FEB 2009, DOI: 10.1002/fps.42

  7. You have free access to this content
    NEW TREATMENT PARADIGM FOR PROSTATE CANCER: ABARELIX INITIATION THERAPY FOR IMMEDIATE TESTOSTERONE SUPPRESSION FOLLOWED BY A LUTEINIZING HORMONE-RELEASING HORMONE AGONIST

    BJU International

    Volume 109, Issue 6, March 2012, Page: E16, Professor Bertrand Tombal

    Version of Record online : 23 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10983.x

  8. You have free access to this content
    The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

    BJU International

    Volume 102, Issue 11, December 2008, Pages: 1531–1538, Laurence Klotz, Laurent Boccon-Gibod, Neal D. Shore, Cal Andreou, Bo-Eric Persson, Per Cantor, Jens-Kristian Jensen, Tine Kold Olesen and Fritz H. Schröder

    Version of Record online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.2008.08183.x

  9. Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 559–566, J. de la Rosette, R. Davis III, D. Frankel and T. Kold Olesen

    Version of Record online : 22 FEB 2011, DOI: 10.1111/j.1742-1241.2011.02637.x

  10. You have free access to this content
    Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males

    The Journal of Physiology

    Volume 561, Issue 2, December 2004, Pages: 637–646, Jason H. Mateika, Qasim Omran, J. A. Rowley, X. S. Zhou, M. P. Diamond and M. Safwan Badr

    Version of Record online : 26 NOV 2004, DOI: 10.1113/jphysiol.2004.071811

  11. You have free access to this content
    Luteinizing hormone-releasing hormone (LHRH) receptor agonists vs antagonists: a matter of the receptors?

    BJU International

    Volume 111, Issue 7, June 2013, Pages: 1021–1030, Yuri Tolkach, Steven Joniau and Hendrik Van Poppel

    Version of Record online : 18 FEB 2013, DOI: 10.1111/j.1464-410X.2013.11796.x

  12. You have free access to this content
    Landmarks in hormonal therapy for prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 23–29, Peter Hammerer and Stephan Madersbacher

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11431.x

  13. Pharmacokinetics and Pharmacodynamics of a Novel Depot Formulation of Abarelix, a Gonadotropin-Releasing Hormone (GnRH) Antagonist, in Healthy Men Ages 50 to 75

    The Journal of Clinical Pharmacology

    Volume 44, Issue 5, May 2004, Pages: 495–502, Dr Shekman L. Wong, Dr David T.-W. Lau, Dr Sharon A. Baughman, Dr Nick Fotheringham, Dr Dora Menchaca and Dr Marc B. Garnick

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004264920

  14. ‘Nurse: My back hurts!’: case study review of Degarelix in metastatic prostate cancer

    International Journal of Urological Nursing

    Volume 5, Issue 2, July 2011, Pages: 90–94, Bruce Turner, Lawrence Drudge-Coates and Jhumur Pati

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1749-771X.2011.01109.x

  15. You have free access to this content
    Concept and viability of androgen annihilation for advanced prostate cancer

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2628–2637, James L. Mohler

    Version of Record online : 25 APR 2014, DOI: 10.1002/cncr.28675

  16. Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review

    European Journal of Clinical Investigation

    Volume 45, Issue 5, May 2015, Pages: 475–484, Matthew L. Romo, Aileen M. McCrillis, Jennifer Brite, Dalicia Reales, Jennifer B. Dowd and C. Mary Schooling

    Version of Record online : 27 APR 2015, DOI: 10.1111/eci.12431

  17. Discovery of LHRH and development of LHRH analogs for prostate cancer treatment

    The Prostate

    Volume 77, Issue 9, June 15, 2017, Pages: 1036–1054, Andrew V. Schally, Norman L. Block and Ferenc G. Rick

    Version of Record online : 27 APR 2017, DOI: 10.1002/pros.23360

  18. Differential mRNA expression profiling in ovarian endometriotic tissue with versus without leuprolide acetate treatment

    Journal of Obstetrics and Gynaecology Research

    Volume 41, Issue 10, October 2015, Pages: 1598–1606, Atsushi Kiba, Kouji Banno, Megumi Yanokura, Mari Asada, Yusuke Nakayama, Daisuke Aoki and Tatsuya Watanabe

    Version of Record online : 15 SEP 2015, DOI: 10.1111/jog.12768

  19. You have free access to this content
    Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

    Intervention Review

    The Cochrane Library

    Hesham G Al-Inany, Mohamed A Youssef, Reuben Olugbenga Ayeleke, Julie Brown, Wai Sun Lam and Frank J Broekmans

    Published Online : 29 APR 2016, DOI: 10.1002/14651858.CD001750.pub4

  20. You have free access to this content
    REPLY

    BJU International

    Volume 109, Issue 6, March 2012, Pages: E16–E17, Marc B. Garnick and Nicolas Mottet

    Version of Record online : 23 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10983_2.x